We need to stop focusing on being present at the office and instead hold employees accountable for measurable results.
Guest Commentary
Stop managing people, and start managing the work.
Now is not the time for “no comment,” says Dara Beevas, co-founder and CEO of Wise Ink Creative Publishing.
Tuition has been too expensive for years, so the health crisis should be the impetus to finally institute important education reforms.
Young professionals are opting out of traditional jobs in droves. It's time to understand why.
How four co-founders are erasing the imaginary line between work
and life—to the benefit of their business and sanity.
Will women’s victories in the November elections inspire evolution in the C-suite?
Nurturing the whole employee builds a stronger business.
Consultants can develop the capacity to serve family businesses after engaging in reflection that helps them become leaders.
When encountering a tense situation with a family business, tell the truth with love instead of fear to resolve conflicts.
In its latest trip to the national spotlight, Duluth was both commended and disparaged by Rolling Stone, a magazine named after a song by a native of the city. Yet, Duluth has much more to offer than what was mentioned in recent coverage.
Every family business must have plans that address ownership, management, the business model and family emotional equity.
Healing sibling resentments and blending two generations of children requires open communication.
Will all disruptive innovation and digital transformation put an end to inflated medical bills?
Succession planning includes not only mentoring the next generation,
but also a good exit strategy for the founder.
Dynamic cities are developing innovation districts.
It probably was the flu, but the escalating rhetoric
and calls to action feel different.
Children may not place the same value on a family business as their parents do, which can create huge conflicts at the time of succession.
Employers should check out ‘outcomes-based’ contracts with drug
companies—you pay only when their high-priced specialty drugs work as promised.
Most businesses continue to cover high-cost medications, but are taking steps to tame spending.